Found 6 matching trials
Study to Evaluate the Effect of Diltiazem Extended Release on the Pharmacokinetics of E2027 in Healthy Subjects PHASE1 This Phase 1, open-label, single-sequence, drug-drug Interaction study is c...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate PHASE1 This study is a single-center, open-label, 3-group, fixed-sequence drug-dru...
Show More Learn More & Join Trial
CiPA Phase 1 ECG Biomarker Validation Study PHASE1 This study will assess whether exposure response analysis of the electrocar...
Show More Location
Spaulding Clinical Research
Learn More & Join Trial
Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441 PHASE1 The aim of the study is to investigate the safety of the concomitant admini...
Show More Learn More & Join Trial
A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects PHASE1 The study is being conducted to assess the effects of co-administration of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Drug-Drug Interaction Study Between Colchicine and Diltiazem ER PHASE1 Colchicine is a substrate for both cytochrome P450 3A4 (CYP3A4) and P-glyco...
Show More Location
PRACS Institute, Ltd. - Cetero Research
Learn More & Join Trial